Table 2.

Microbiologic Data for Patients With community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft-tissue infections (SSTI), n = 73

AntibioticMIC50 (μg/mL)MIC90 (μg/mL)% of Isolates Susceptible
TMP-SMX0.060.12100
Doxycycline0.060.06100
Clindamycin0.060.1293
Linezolid1.02.0100
Vancomycin2.02.0100
  • TMP-SMX, trimethoprim-sulfamethoxazole.